I like this bit... " “Previous studies have used ResAppDx to...

I like this bit...
"
“Previous studies have used ResAppDx to diagnose one disease from another. This is the first study where ResAppDx has been used to diagnose a full range of respiratory diseases among a group of patients with a variety of ailments, which is a much greater challenge than previously reported. The excellent results achieved reaffirm the performance of ResAppDx and give us a great deal of confidence as we enter the analysis phase of SMARTCOUGH-C and prepare our de novo submission to the US FDA,” said Dr Tony Keating, CEO and Managing Director of ResApp Health."

All aligned and set for excellent US trial results.
Fox